Evidence map›Paper›PMID 20546566›Full record

ArticleMicrobial cell factories2010

MARINE-EXPRESS: taking advantage of high throughput cloning and expression strategies for the post-genomic analysis of marine organisms.

Agnès Groisillier, Cécile Hervé, Alexandra Jeudy, Etienne Rebuffet, Pierre F Pluchon, Yann Chevolot, Didier Flament, Claire Geslin, Isabel M Morgado, Déborah Power and 5 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Isolation of Antimicrobial Genes fromInternational journal of molecular sciences · 2020
    Article
  5. Article
  6. Article
  7. The agar-specific hydrolaseThe Journal of biological chemistry · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Complete Genome Sequence of the Fish PathogenFrontiers in microbiology · 2017
    Article
  13. Enzyme-Assisted Preparation of Furcellaran-Like κ-/β-Carrageenan.Marine biotechnology (New York, N.Y.) · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 4 countries.

Agnès GroisillierUPMC Univ Paris 6, UMR 7139 Végétaux marins et Biomolécules, LIA DIAMS, Station Biologique, Roscoff, France.
Cécile Hervé
Alexandra Jeudy
Etienne Rebuffet
Pierre F Pluchon
Yann Chevolot
Didier Flament
Claire Geslin
Isabel M Morgado
Déborah Power
Margherita Branno
Hervé Moreau
Gurvan Michel
Catherine Boyen
Mirjam Czjzek
Laboratoire des Biomolécules · FRUniversité de Bretagne Occidentale · FRSorbonne Université · FRUniversity of Algarve · PTCentre National de la Recherche Scientifique · FRÉcole Centrale de Lyon · FRObservatoire Océanologique de Banyuls-sur-Mer · FRStazione Zoologica Anton Dohrn · ITUPMC Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe production of stable and soluble proteins is one of the most important steps prior to structural and functional studies of biological importance. We investigated the parallel production in a medium throughput strategy of genes coding for proteins from various marine organisms, using protocols that involved recombinatorial cloning, protein expression screening and batch purification. This strategy was applied in order to respond to the need for post-genomic validation of the recent success of a large number of marine genomic projects. Indeed, the upcoming challenge is to go beyond the bioinformatic data, since the bias introduced through the genomes of the so called model organisms leads to numerous proteins of unknown function in the still unexplored world of the oceanic organisms.

resultsWe present here the results of expression tests for 192 targets using a 96-well plate format. Genes were PCR amplified and cloned in parallel into expression vectors pFO4 and pGEX-4T-1, in order to express proteins N-terminally fused to a six-histidine-tag and to a GST-tag, respectively. Small-scale expression and purification permitted isolation of 84 soluble proteins and 34 insoluble proteins, which could also be used in refolding assays. Selected examples of proteins expressed and purified to a larger scale are presented.

conclusionsThe objective of this program was to get around the bottlenecks of soluble, active protein expression and crystallization for post-genomic validation of a number of proteins that come from various marine organisms. Multiplying the constructions, vectors and targets treated in parallel is important for the success of a medium throughput strategy and considerably increases the chances to get rapid access to pure and soluble protein samples, needed for the subsequent biochemical characterizations. Our set up of a medium throughput strategy applied to genes from marine organisms had a mean success rate of 44% soluble protein expression from marine bacteria, archaea as well as eukaryotic organisms. This success rate compares favorably with other protein screening projects, particularly for eukaryotic proteins. Several purified targets have already formed the base for experiments aimed at post-genomic validation.

Indexed as

AnimalsArchaeal ProteinsBacterial ProteinsCloning, MolecularComputational BiologyEukaryotaFlavobacteriaceaeHigh-Throughput Screening AssaysPlasmidsPyrococcus abyssiRecombinant Fusion ProteinsSea BreamArchaeal ProteinsBacterial ProteinsRecombinant Fusion Proteins

Identifiers

PMID20546566
PMCPMC2897777
OpenAlexW2068491029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.